SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
Discover600276.SS
HealthcareShanghaiUSD

Jiangsu Hengrui Pharmaceuticals

$0012345678900123456789.0012345678900123456789+15.2%
52w low (est.) $45.15$66.38 52w high (est.)
Peers
Market data
Market cap
CN¥370.02B
52-week range
CN¥45.26 – CN¥74.04
Beta (vs market)
0.12
Sector
Healthcare
Valuation
P/E ratio
45.7x
DCF fair value
CN¥34.71
Margin of safety
-35.9%
Forward P/E
31.6x
PEG ratio
0.93
Dividend yield
0.36%
Quality & efficiency
Moat score
85/100
Return on equity
14.5%
Profit margin
24.9%
Growth & analysts
Revenue growth (YoY)
+13.0%

About Jiangsu Hengrui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Valuation

ValueGrowthProfitHealthIncome46QUALITY
Overall Rating
44
Reduce
Reduce
Moat Score85
DCF Intrinsic Value
CN¥34.71-35.9% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
CN¥370.02B
P/E Ratio
45.7
Dividend Yield
0.36%
Revenue Growth
+13.0%
Profit Margin
24.9%
ROE
14.5%
Debt / Equity
0.00
Beta
0.12
vs Healthcare sector:P/E 46 vs 28 Moat 85 vs 7Yield 0.36% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · 600276.SS